Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal L24 domain containing 1 pseudogene 6 (RSL24D1P6) is annotated as a human pseudogene, showing sequence similarity to genes encoding proteins with a ribosomal L24 domain, specifically the functional RSL24D1 protein-coding gene. However, RSL24D1P6 does not produce a functional protein and is not involved in any known molecular, biological, or disease processes. It has alternate aliases but is not referenced in the context of a therapeutic or diagnostic target. No biomarker or pharmacological activities are associated with this gene, and it does not present therapeutic safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal L24 domain containing 1 pseudogene 6 (RSL24D1P6).